Zhang X et al. |
Agonist-dependent potentiation of vanilloid receptor transient receptor potential vanilloid type 1 function by stilbene derivatives. |
2012 |
Mol. Pharmacol. |
pmid:22328719
|
Rajesh M et al. |
Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. |
2012 |
Diabetes |
pmid:22315315
|
Shi RZ et al. |
Decreased anandamide transporter activity and calcitonin gene-related peptide production in spontaneously hypertensive rats: role of angiotensin II. |
2012 |
Eur. J. Pharmacol. |
pmid:22318155
|
Battista N et al. |
The role of endocannabinoids in gonadal function and fertility along the evolutionary axis. |
2012 |
Mol. Cell. Endocrinol. |
pmid:22305972
|
Liu J et al. |
Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. |
2012 |
Gastroenterology |
pmid:22307032
|
Fowler CJ |
Anandamide uptake explained? |
2012 |
Trends Pharmacol. Sci. |
pmid:22297258
|
Izzo AA et al. |
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. |
2012 |
Br. J. Pharmacol. |
pmid:22300105
|
Chon SH et al. |
Over-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesity. |
2012 |
PLoS ONE |
pmid:22937137
|
Moreno-Sanz G et al. |
Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier. |
2012 |
Br. J. Pharmacol. |
pmid:22774772
|
Rettori E et al. |
Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat. |
2012 |
Neuroimmunomodulation |
pmid:22777139
|
Luchicchi A and Pistis M |
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. |
2012 |
Mol. Neurobiol. |
pmid:22801993
|
Krishnan G and Chatterjee N |
Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation. |
2012 |
Glia |
pmid:22807196
|
Romano MR and Lograno MD |
Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery. |
2012 |
Eur. J. Pharmacol. |
pmid:22429572
|
Xiong W et al. |
A common molecular basis for exogenous and endogenous cannabinoid potentiation of glycine receptors. |
2012 |
J. Neurosci. |
pmid:22496565
|
Chicca A et al. |
Evidence for bidirectional endocannabinoid transport across cell membranes. |
2012 |
J. Biol. Chem. |
pmid:22879589
|
Leweke FM et al. |
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. |
2012 |
Transl Psychiatry |
pmid:22832859
|
Kuc C et al. |
Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade. |
2012 |
Mol. Carcinog. |
pmid:21432910
|
Skaper SD and Di Marzo V |
Endocannabinoids in nervous system health and disease: the big picture in a nutshell. |
2012 |
Philos. Trans. R. Soc. Lond., B, Biol. Sci. |
pmid:23108539
|
Di Marzo V and De Petrocellis L |
Why do cannabinoid receptors have more than one endogenous ligand? |
2012 |
Philos. Trans. R. Soc. Lond., B, Biol. Sci. |
pmid:23108541
|
Puighermanal E et al. |
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids. |
2012 |
Philos. Trans. R. Soc. Lond., B, Biol. Sci. |
pmid:23108544
|
Starowicz K and Przewlocka B |
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system. |
2012 |
Philos. Trans. R. Soc. Lond., B, Biol. Sci. |
pmid:23108547
|
Rani Sagar D et al. |
Dynamic changes to the endocannabinoid system in models of chronic pain. |
2012 |
Philos. Trans. R. Soc. Lond., B, Biol. Sci. |
pmid:23108548
|
Campos AC et al. |
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. |
2012 |
Philos. Trans. R. Soc. Lond., B, Biol. Sci. |
pmid:23108553
|
Lipina C et al. |
New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance. |
2012 |
Bioessays |
pmid:22674489
|
Zoerner AA et al. |
Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction. |
2012 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:21752730
|
Goonawardena AV et al. |
Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus. |
2011 Oct-Nov |
Neuropharmacology |
pmid:21767554
|
Andrianova EL et al. |
In vitro effects of anandamide and prostamide e2 on normal and transformed nerve cells. |
2011 |
Bull. Exp. Biol. Med. |
pmid:22442796
|
Walentiny DM et al. |
The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice. |
2011 |
Eur. J. Pharmacol. |
pmid:21300050
|
Bari M et al. |
Characterization of the endocannabinoid system in mouse embryonic stem cells. |
2011 |
Stem Cells Dev. |
pmid:20446814
|
Weller K et al. |
TRPV1, TRPA1, and CB1 in the isolated vagus nerve--axonal chemosensitivity and control of neuropeptide release. |
2011 |
Neuropeptides |
pmid:21868092
|
Aberturas MR et al. |
Anandamide-loaded nanoparticles: preparation and characterization. |
2011 |
J Microencapsul |
pmid:21425945
|
Pinar-Sueiro S et al. |
[Cannabinoid applications in glaucoma]. |
2011 |
Arch Soc Esp Oftalmol |
pmid:21414525
|
Mukhopadhyay B et al. |
Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21383171
|
Rossi S et al. |
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis. |
2011 |
Brain Behav. Immun. |
pmid:21473912
|
Gamaleddin I et al. |
The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake. |
2011 |
Br. J. Pharmacol. |
pmid:21501143
|
Howlett AC et al. |
Endocannabinoid tone versus constitutive activity of cannabinoid receptors. |
2011 |
Br. J. Pharmacol. |
pmid:21545414
|
Carr RL et al. |
Effect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile rats. |
2011 |
Toxicol. Sci. |
pmid:21507991
|
Di Marzo V |
Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. |
2011 |
Nat. Neurosci. |
pmid:21187849
|
Bari M et al. |
The manifold actions of endocannabinoids on female and male reproductive events. |
2011 |
Front Biosci (Landmark Ed) |
pmid:21196184
|
Guindon J et al. |
Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain. |
2011 |
Br. J. Pharmacol. |
pmid:21198549
|
Liao YS et al. |
[Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts]. |
2011 |
Zhonghua Zhong Liu Za Zhi |
pmid:21575494
|
Shekhar C |
Mixed signals: cannabinoid system offers new therapeutic possibilities as well as challenges. |
2011 |
Chem. Biol. |
pmid:21609833
|
Umathe SN et al. |
Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. |
2011 |
Behav. Brain Res. |
pmid:21549765
|
Arias-Carrión O et al. |
Biochemical modulation of the sleep-wake cycle: endogenous sleep-inducing factors. |
2011 |
J. Neurosci. Res. |
pmid:21557294
|
Hutchins HL et al. |
Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells. |
2011 |
J. Nutr. Biochem. |
pmid:20951563
|
Gervasi MG et al. |
Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation. |
2011 |
PLoS ONE |
pmid:21347292
|
Mestre L et al. |
Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors. |
2011 |
J Neuroinflammation |
pmid:21851608
|
Feledziak M et al. |
SAR and LC/MS studies of β-lactamic inhibitors of human fatty acid amide hydrolase (hFAAH): evidence of a nonhydrolytic process. |
2011 |
J. Med. Chem. |
pmid:21899370
|
Palermo G et al. |
Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas. |
2011 |
J. Med. Chem. |
pmid:21830831
|
Zoerner AA et al. |
Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma. |
2011 |
Clin. Pharmacol. Ther. |
pmid:21716266
|